杰地集團(08313.HK)投標取得對新加坡一住宅重建項目 作價1,800萬坡元
杰地集團(08313.HK)公布,已成功通過其全資子公司ZACD,以指定一間全資擁有的特殊目的發展實體,投標取得對新加坡艾米莉路2,2A,2B,4,4A,4B,6,6A和6B號的永久業權土地住宅重建項目。該項目作價1,800萬坡元,預期於5月25日完成交易。
待基金結構及基金文件最終確定時,該發展實體將由一間公司間接全資擁有的特殊目的基金實體持有或代為持有。目前該基金正在設立中。
董事會相信,艾米莉項目將成為集團及集團基金投資者一項甚具吸引力的房地產投資機遇。該基金的成功設立,預期將為集團的投資管理服務業務帶來貢獻。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.